CSL (OTCMKTS:CSLLY) Shares Gap Down - Time to Sell?

Key Points

• CSL Limited's shares experienced a significant gap down, opening at $67.50 after a previous close of $69.48 before last trading at $68.00.
• The company's financial ratios include a quick ratio of 0.85 and a current ratio of 1.86, indicating potential liquidity concerns.
• CSL operates through multiple segments, notably CSL Behring, which focuses on plasma products, gene therapies, and recombinants, highlighting its diverse biopharmaceutical offerings.

CSL Limited Sponsored ADR (OTCMKTS:CSLLY - Get Free Report) shares gapped down before the market opened on Thursday . The stock had previously closed at $69.48, but opened at $67.50. CSL shares last traded at $68.00, with a volume of 2,461 shares trading hands.

CSL Price Performance

The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.12 and a current ratio of 2.46. The firm's 50-day simple moving average is $78.90 and its 200 day simple moving average is $78.75.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.